Dishman Carbogen Amcis Ltd
NSE:DCAL
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
136.5
273.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one DCAL stock under the Base Case scenario is 232.67 INR. Compared to the current market price of 228.44 INR, Dishman Carbogen Amcis Ltd is Undervalued by 2%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Dishman Carbogen Amcis Ltd
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for DCAL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Dishman Carbogen Amcis Ltd
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Dishman Carbogen Amcis Ltd
Balance Sheet Decomposition
Dishman Carbogen Amcis Ltd
Current Assets | 19.3B |
Cash & Short-Term Investments | 4.5B |
Receivables | 4.6B |
Other Current Assets | 10.1B |
Non-Current Assets | 76.5B |
Long-Term Investments | 1.1B |
PP&E | 32.3B |
Intangibles | 41.3B |
Other Non-Current Assets | 1.8B |
Current Liabilities | 25.5B |
Accounts Payable | 2.4B |
Other Current Liabilities | 23.1B |
Non-Current Liabilities | 14B |
Long-Term Debt | 5.3B |
Other Non-Current Liabilities | 8.7B |
Earnings Waterfall
Dishman Carbogen Amcis Ltd
Revenue
|
24.2B
INR
|
Cost of Revenue
|
-5B
INR
|
Gross Profit
|
19.2B
INR
|
Operating Expenses
|
-20.3B
INR
|
Operating Income
|
-1.1B
INR
|
Other Expenses
|
-1.4B
INR
|
Net Income
|
-2.5B
INR
|
Free Cash Flow Analysis
Dishman Carbogen Amcis Ltd
INR | |
Free Cash Flow | INR |
DCAL Profitability Score
Profitability Due Diligence
Dishman Carbogen Amcis Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
Score
Dishman Carbogen Amcis Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
DCAL Solvency Score
Solvency Due Diligence
Dishman Carbogen Amcis Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Score
Dishman Carbogen Amcis Ltd's solvency score is 42/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DCAL Price Targets Summary
Dishman Carbogen Amcis Ltd
Dividends
Current shareholder yield for DCAL is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Ownership
DCAL Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2017-09-21. The firm's segments include CRAMS and Vitamin - D, Bulk Drugs, Quats, Specialty Chemicals and traded goods. The firm assists pharma companies through various stages of drug development from process research and development to late-stage clinical and commercial manufacturing facilities, along with the supply of active pharmaceutical ingredients (APIs) and intermediates. The firm has manufacturing and research facilities in India, Switzerland, France, Netherlands, United Kingdom and China. The firm's subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., Dishman Carbogen Amcis (Singapore) Pte. Ltd., CARBOGEN AMCIS Holding AG and Dishman Biotech Ltd.
Contact
IPO
Employees
Officers
The intrinsic value of one DCAL stock under the Base Case scenario is 232.67 INR.
Compared to the current market price of 228.44 INR, Dishman Carbogen Amcis Ltd is Undervalued by 2%.